3-(thiophen-2-yl)-1,2-oxazol-5-ol, 95.0%, 10g

1,3-Diphenylpropan-1-amine hydrochloride, 97%, 1g

Methyl 1-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-5-carboxylate, 95+%, 1g

6-chloro-9-nitro-5H-benzo[a]phenoxazin-5-one, 95.0%, 250mg

(1-Methylpiperidin-4-yl)boronic acid, 98%, 250mg

2-Hydroxy-4-methylthiazole-5-carboxylic acid, 95.0%, 25g

3-Hydroxy-4-methylbenzoic acid, min. 98%, for synthesis, 25 g, plastic packaging.

4-(4-Methyl-4H-1,2,4-triazol-3-yl)pyridine, 95%, 250mg

2-Amino-3-cyanothiophene, 99.0%, 1g

N-Benzyl-N-cyclopropylcyclopropanamine, 97%, 5g

4,7-Diazaspiro[2.5]octan-6-one, 98%, 250mg

3-Amino-1H-indazole-4-carbonitrile, 95.0%, 1g

4-Bromo-2-fluoro-6-(trifluoromethyl)phenol, 95.0%, 5g